Table 1.
Clinical and laboratory characteristics of the participants.
| n = 183 | |
|---|---|
| Age (year) | 68 ± 13 |
| Sex male (%) | 105 (57.6) |
| BMI (kg/m2) | 20.7 ± 3.5 |
| SBP (mmHg) | 144 ± 25 |
| DBP (mmHg) | 79 ± 13 |
| Period of hemodialysis (months) | 71 (31–142) |
| Kt/v | 1.83 ± 0.35 |
| Serum albumin (g/dl) | 3.5 (3.3–3.8) |
| Serum Creatinine (mg/dl) | 7.7 (6.3–9.0) |
| Serum Ca (mg/dl) | 8.4 (7.8–8.8) |
| Serum P (mg/dl) | 5.0 (4.1–5.7) |
| iPTH (pg/ml) | 151.0 (81.0–207.8) |
| BAP (µg/l) | 14.9 (11.5–20.7) |
| Ferritin (ng/ml) | 91.0 (49.9–181.9) |
| TSAT (%) | 27 (19–35) |
| CRP (mg/dl) | 0.2 (0.1–0.4) |
| CPP | |
| Crystalline CaPi (AU) | 7922 (5381–12,204) |
| Total CaPi (AU) | 39,584 (19,075–67,576) |
| Amorphous CaPi (AU) | 32,047 (12,619–54,245) |
| Amorphous CaPi ratio | 0.77 (0.65–0.83) |
Data are expressed as mean ± SD or number or median (interquartile range). BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, iPTH intact parathyroid hormone, BAP bone specific alkaline phosphatase, TSAT transferrin saturation, CRP C-reactive protein.